Clinical Trial Update: Ultra-Hypofractionated vs. Moderately Hypofractionated Proton Therapy for Early Breast Cancer After Lumpectomy [NA]

View source ↗

Summary

A clinical trial is evaluating ultra-hypofractionated versus moderately hypofractionated proton therapy for early breast cancer after lumpectomy, with recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Shanghai Proton and Heavy Ion Center | Conditions: Breast Cancer, Proton Therapy | NA | Status: RECRUITING